Gene · 8519
IFITM1: interferon induced transmembrane protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IFITM1: interferon induced transmembrane protein 1. Genes, record 8519. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8519
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P13164 | Interferon-induced transmembrane protein 1 | 125 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 50046 | P13164 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 50047 | P13164 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 50049 | P13164 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5874 | P13164 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 315 | P13164 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2037 | P13164 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2037 | P13164 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5874 | P13164 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 315 | P13164 | Espacenet |
| US 12024722 B2 | 2024-07-02 | 62 | P13164 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,211
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IFITM1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 11 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 9 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 7 | 2025 |
| P30CA168524 | The University of Kansas Cancer Center | 7 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 7 | 2025 |
| ZIABC011779 | Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry | 7 | 2025 |
| P30AI036214 | San Diego Center for AIDS Research (SD CFAR) | 6 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 6 | 2025 |
| R01AI130110 | Mechanisms of innate resistance to virus infections | 6 | 2025 |
1 to 10 of 2,211Source NIH's project files
See all 2,211 nih grantsPapers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell and bulk transcriptomic analyses define an IFI27-centered interferon-response epithelial state in bladder cancer and its transcriptional response to irradiation. | Front Cell Dev Biol | 2026 | 42798643 | PubTator, text mining | PubMed |
| Transcriptomic characterization of transitional B cells reveals four subsets with perturbed activation profiles in scleroderma. | iScience | 2026 | 42774868 | PubTator, text mining | PubMed |
| Identification of Critical Genes for Recurrent Aphthous Ulcer by Transcriptome Data Analysis and Mendelian Randomization. | Oral Health Prev Dent | 2026 | 42714320 | PubTator, text mining | PubMed |
| IFITM1 enhances anti-tumor function of unconventional TCRαβ double negative T cells by upregulating mitophagy. | Sci China Life Sci | 2026 | 42667541 | PubTator, text mining | PubMed |
| A Multi-Layered Proteogenomic Framework for the Prioritization of Cell Surface Therapeutic Targets: Proof-of-Concept for Metastatic Colorectal Cancer. | Cancers (Basel) | 2026 | 42649884 | PubTator, text mining | PubMed |
| Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome. | PLoS One | 2026 | 42647509 | PubTator, text mining | PubMed |
| Interferon-induced transmembrane (IFITM) proteins at the tumour-immune interface: A four-axis framework for their context-dependent roles. | Clin Transl Med | 2026 | 42613969 | PubTator, text mining | PubMed |
| Retraction notice to "The role and mechanism of IFITM1 in developing acquired cisplatin resistance in small cell lung cancer" [Heliyon 10 (2024) e30806]. | Heliyon | 2026 | 42581850 | PubTator, text mining | PubMed |
| Screening for candidate genes and cell populations associated with atherosclerotic calcification using single-cell RNA sequencing. | Mamm Genome | 2026 | 42581084 | PubTator, text mining | PubMed |
| Determinants of response to neoadjuvant chemotherapy in breast cancer: Integrated roles of immune pathways, DNA damage response, and cell cycle regulators. | Mol Biol Rep | 2026 | 42530655 | PubTator, text mining | PubMed |
1 to 10 of 2,758
See all 2,758 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8519
GET https://conductscience.org/api/genes/v1/8519/patents?page=2